- Home
- SHOO vs XENE Comparison
SHOO vs XENE Comparison
Compare SHOO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOO
- XENE
- Stock Information
- Founded
- SHOO 1990
- XENE 1996
- Country
- SHOO United States
- XENE Canada
- Employees
- SHOO N/A
- XENE N/A
- Industry
- SHOO Shoe Manufacturing
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- SHOO Consumer Discretionary
- XENE Health Care
- Exchange
- SHOO Nasdaq
- XENE Nasdaq
- Market Cap
- SHOO 3.1B
- XENE 3.3B
- IPO Year
- SHOO 1993
- XENE 2014
- Fundamental
- Price
- SHOO $43.80
- XENE $41.48
- Analyst Decision
- SHOO Hold
- XENE Strong Buy
- Analyst Count
- SHOO 8
- XENE 9
- Target Price
- SHOO $46.00
- XENE $56.67
- AVG Volume (30 Days)
- SHOO 657.8K
- XENE 361.3K
- Earning Date
- SHOO 11-07-2024
- XENE 11-12-2024
- Dividend Yield
- SHOO 1.94%
- XENE N/A
- EPS Growth
- SHOO 6.16
- XENE N/A
- EPS
- SHOO 2.36
- XENE N/A
- Revenue
- SHOO $2,220,323,000.00
- XENE N/A
- Revenue This Year
- SHOO $15.82
- XENE N/A
- Revenue Next Year
- SHOO $5.23
- XENE $1,599.99
- P/E Ratio
- SHOO $18.40
- XENE N/A
- Revenue Growth
- SHOO 14.89
- XENE N/A
- 52 Week Low
- SHOO $37.99
- XENE $35.53
- 52 Week High
- SHOO $50.01
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- SHOO 43.08
- XENE 46.22
- Support Level
- SHOO $43.24
- XENE $38.95
- Resistance Level
- SHOO $44.44
- XENE $41.62
- Average True Range (ATR)
- SHOO 0.85
- XENE 1.46
- MACD
- SHOO -0.09
- XENE -0.13
- Stochastic Oscillator
- SHOO 3.98
- XENE 38.06
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.